DARKOVNA JUSTE: Open Payments
NPI 1396508883 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 31 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $281 · 2025 $1,310
Food & beverage: $1,310
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $318 |
| Teva Pharmaceuticals USA, Inc. | 6 | $260 |
| Janssen Pharmaceuticals, Inc | 4 | $232 |
| Otsuka America Pharmaceutical, Inc. | 8 | $223 |
| E.R. Squibb & Sons, L.L.C. | 2 | $143 |
| ABBVIE INC. | 3 | $77 |
| Neurocrine BioSciences, Inc. | 2 | $57 |
Products named: CAPLYTA, INVEGA SUSTENNA, COBENFY, UZEDY, AUSTEDO XR, ABILIFY MAINTENA, VRAYLAR, REXULTI.
Industry payments across MA — which companies pay providers there.
